City

Chicago (1)

Cleveland (1)

Dallas (1)

Hannover (1)

Houston (1)

New York (1)

Winston-Salem (1)

Condition

Secondary Acute Myeloid Leukemia (AML) (2)

De Novo Akute Myeloid Leukemia (AML) (1)

Myelodysplastic Syndromes (1)

Refractory Anemia With Excess of Blasts in Transformation (1)

Overall Status

Completed (1)

Unknown status (1)

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Genzyme, a Sanofi Company (1)

Hannover Medical School (1)

Intervention

clofarabine (1)

cytarabine (1)

daunorubicine (1)

etoposide (1)

fludarabine (1)

g-csf (1)

idarubicin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

secondary acute myeloid leukemia (aml)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed

Has Results

Myelodysplastic Syndromes
Secondary Acute Myeloid Leukemia (AML)

Clofarabine

Chicago, Illinois
+5 more

Mar 15, 2022

De Novo Akute Myeloid Leukemia (AML), Secondary Acute Myeloid Leukemia (AML), Refractory Anemia With Excess of Blasts in

Unknown status

De Novo Akute Myeloid Leukemia (AML)
+2 more

Cytarabine
+5 more

Hannover, Germany

Hannover Medical School

Nov 17, 2005